C. Allen Chang,Hsin-Ell Wang,Jia-Je Li,Shun-Fu Chang,Roy Chen-Chih Wu
申请号：
US16247489
公开号：
US20190211057A1
申请日:
2019.01.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a targeted prodrug enzyme fusion carrier comprising a targeted molecule and a prodrug enzyme. The targeted prodrug enzyme fusion carrier can effectively identify and bind to tumor cells and tumor-induced tumor angiogenesis. The targeted prodrug enzyme fusion carrier also has a targeted prodrug enzyme fusion protein and a theranostic system utilizing the method of in vivo nuclear medicine for the clinical diagnosis and treatment of individual patients with tumors.
